Cargando…

Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease

PURPOSE: There is no universal consensus on second-line agents for the treatment of moderate/severe to sight-threatening thyroid eye disease (TED) to maintain remission after first-line intravenous methylprednisolone (IVMP). This study investigates the efficacy and safety of mycophenolate mofetil (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quah Qin Xian, Nicole, Alnahrawy, Ahmed, Akshikar, Rashmi, Lee, Vickie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121682/ https://www.ncbi.nlm.nih.gov/pubmed/34007144 http://dx.doi.org/10.2147/OPTH.S305717

Ejemplares similares

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
por: Philobos, Mariana, et al.
Publicado: (2021)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
por: Li, Lan-Fang, et al.
Publicado: (2023)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study
por: LEE, Kyung-Ann, et al.
Publicado: (2020)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
por: Zhang, Xiaohui, et al.
Publicado: (2023)

MANAGEMENT OF ERYTHEMA NODOSUM LEPROSUM BY MYCOPHENOLATE MOFETIL
por: Banerjee, Kalyan, et al.
Publicado: (2008)

Perforated Jejunal Diverticulum in the Use of Mycophenolate Mofetil
por: Thongprayoon, Charat, et al.
Publicado: (2014)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Park, Seung Woon, et al.
Publicado: (2016)

Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil
por: Sonoda, Akira, et al.
Publicado: (2017)

Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil
por: Koratala, Abhilash, et al.
Publicado: (2018)

Treatment of Kimura disease with mycophenolate mofetil monotherapy
por: Shah, Kalee, et al.
Publicado: (2017)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
por: Kim, Joyce J., et al.
Publicado: (2020)

Acute Mycophenolate Mofetil Overdose Managed Conservatively
por: Sharma, Prabhat, et al.
Publicado: (2021)

Mycophenolate mofetil product monograph updated in Canada
Publicado: (2021)

Mycophenolate-mofetil/valganciclovir: Neutropenia: case report
Publicado: (2022)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
por: Yim, Rebecca M., et al.
Publicado: (2023)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy
por: Rajabi, Mohammad Taher, et al.
Publicado: (2022)

Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis
por: Feng, Wenwen, et al.
Publicado: (2022)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis
por: Nambiar, Anoop M., et al.
Publicado: (2017)

Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020)

Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021)

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020)

Recalcitrant lymphocytoma cutis successfully treated with mycophenolate mofetil
por: Mahmood, Farhan, et al.
Publicado: (2021)

Mycophenolate-mofetil: COVID-19 pneumonia: case report
Publicado: (2021)

Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022)

Mycophenolate-mofetil/prednisone: Lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9tg5ereqsj04cf2j87nmhiat22